[1]
2026. Routine clinical and laboratory factors as predictive markers for non‑response to ABVD chemotherapy in classical Hodgkin lymphoma: a prospective cohort study. Latakia University (formerly Tishreen) Journal for Research and Scientific Studies - Health Sciences Series. 48, 3 (Aug. 2026), 171–181.